Stay updated with breaking news from 91307c10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) EVP Paul A. Mahon sold 6,000 shares of the stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $236.25, for a total transaction of $1,417,500.00. Following the completion of the sale, the executive vice president now directly owns 36,599 […]
United Therapeutics (NASDAQ:UTHR – Free Report) had its price objective raised by LADENBURG THALM/SH SH from $256.00 to $268.00 in a report released on Thursday morning, MarketBeat reports. They currently have a buy rating on the biotechnology company’s stock. Several other brokerages have also weighed in on UTHR. Argus cut their price target on United […]
United Therapeutics (NASDAQ:UTHR – Free Report) had its price target hoisted by Wedbush from $305.00 to $307.00 in a report published on Thursday morning, Benzinga reports. The firm currently has an outperform rating on the biotechnology company’s stock. A number of other analysts have also commented on UTHR. Argus cut their price objective on shares […]
United Therapeutics (NASDAQ:UTHR – Free Report) had its price target boosted by LADENBURG THALM/SH SH from $256.00 to $268.00 in a research report released on Thursday morning, MarketBeat Ratings reports. LADENBURG THALM/SH SH currently has a buy rating on the biotechnology company’s stock. Several other analysts have also recently commented on the stock. Morgan Stanley […]
United Therapeutics (NASDAQ:UTHR – Free Report) had its price objective upped by LADENBURG THALM/SH SH from $256.00 to $268.00 in a research note published on Thursday morning, MarketBeat Ratings reports. They currently have a buy rating on the biotechnology company’s stock. UTHR has been the subject of a number of other reports. Morgan Stanley decreased […]